Who We Are

Purdue Pharma L.P. is a pharmaceutical company committed to improving patients' lives and serving the healthcare community.

PrintFont Size

Partnering With Purdue

THE BENEFITS OF PARTNERING WITH PURDUE

Purdue is dedicated to serving healthcare professionals and patients with clinically-differentiated products and supporting services to treat both the disease and its symptoms. By focusing on areas within our specialty of the pain management and primary care market, Purdue generates outstanding commercial success. We bring our product development expertise and collaborative culture to building significant products in long-term relationships with innovative organizations. Your partnered product will be important to Purdue.

Fully Integrated Pharmaceutical Operations

Purdue provides partner companies with extensive expertise in discovery, clinical development, project management, regulatory affairs, manufacturing, marketing, and sales. A dedicated Alliance Management function ensures that every dimension and detail involved in our collaborations gets the attention required.

Purdue has regulatory expertise and experience in gaining approvals from the U.S. Food and Drug Administration (FDA). Our national U.S. Sales and Marketing organization has the critical mass and skills to commercialize new products quickly and effectively.

Global Reach

Purdue and its independent associated companies (including the Mundipharma/Napp companies) have a presence in more than 30 countries and the collective strength of more than 5,000 employees worldwide. Each of these international companies is a leader within their respective market for key therapeutic areas, as well as shares in a common interest in pain management.

Expertise in Pain Management

Purdue has long-standing expertise in pain management and over the course of more than three decades has transformed clinical practice to better serve the needs of patients with pain. We have conducted extensive research into the development of analgesics with the goal of providing safe and effective pain relief to patients. We work closely with physicians, opinion leaders, and patient advocacy groups to ensure that pain is appropriately recognized and treated. Purdue’s research center in Cranbury, New Jersey, is focused on the discovery of new molecular entities which modulate pain.

Expanding into New Therapeutic Areas

Purdue has an exclusive license and collaboration agreement with Transcept Pharmaceuticals, Inc., to commercialize Intermezzo® (zolpidem tartrate) sublingual tablet.

Purdue ’s Therapeutic Areas of Interest

Purdue’s licensing strategy seeks to identify late-stage (post-Proof of Concept) products within the following therapeutic areas:

  • Pain management — both non-opioids and opioids
  • Neuroscience — sleep disorders
  • Gastrointestinal disorders
  • Opportunistic primary care products

Licensing & Business Development Contacts at Purdue:

For any new opportunities in Purdue’s therapeutic areas of interest, please contact:

Sue Yao
Sr. Manager
Licensing & Business Development
+1-203-588-7771
sue.yao@pharma.com

Christian Darland
Manager
Licensing & Business Development
+1-203-588-7416
christian.darland@pharma.com

close  x

Email to a Friend or Colleague

Thank you! The page has been sent.

There was a problem sending this page, please try again.

Enter your email address and your friend’s email address,
then click the Send button.

*Indicates a required field

Sender’s email:*

Recipient’s email:*

Message: (max 500 characters)


No personal information including e-mail addresses about you or the recipient will be collected from this email notification feature offered by Purdue Pharma, L.P.

close  x